Global PEGylated Proteins Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global PEGylated Proteins Market
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.

Due to the COVID-19 pandemic, the global PEGylated Proteins market size is estimated to be worth US$ 3924.4 million in 2022 and is forecast to a readjusted size of US$ 4908.6 million by 2028 with a CAGR of 3.8% during the review period. Fully considering the economic change by this health crisis, Colony Stimulating Factors accounting for % of the PEGylated Proteins global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Cancer Treatment segment is altered to an % CAGR throughout this forecast period.

The major players in global PEGylated Proteins market include UCB, Pfizer, etc. The top 2 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy over 60% of the global market. Colony Stimulating Factors and Interferons are two main types, with a share over 40% altogether. Rheumatoid Arthritis & Crohn's Disease and Cancer Treatment are two key applications, they hold about 60% shares.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Colony Stimulating Factors

Interferons

Erythropoietin (EPO)

Recombinant Factor VIII

Monoclonal Antibodies

Others

Segment by Application

Cancer Treatment

Hepatitis

Chronic Kidney Disease

Leukemia

SCID

Rheumatoid Arthritis & Crohn's Disease

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the PEGylated Proteins market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

ENZON Pharmaceuticals

Merck Sharp & Dohme

Roche

Pfizer

Amgen

UCB

Crealta (Savient)

TABLE OF CONTENT

1 Study Coverage
1.1 PEGylated Proteins Product Introduction

1.2 Market by Type

1.2.1 Global PEGylated Proteins Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Colony Stimulating Factors

1.2.3 Interferons

1.2.4 Erythropoietin (EPO)

1.2.5 Recombinant Factor VIII

1.2.6 Monoclonal Antibodies

1.2.7 Others

1.3 Market by Application

1.3.1 Global PEGylated Proteins Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Cancer Treatment

1.3.3 Hepatitis

1.3.4 Chronic Kidney Disease

1.3.5 Leukemia

1.3.6 SCID

1.3.7 Rheumatoid Arthritis & Crohn's Disease

1.3.8 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global PEGylated Proteins Sales Estimates and Forecasts 2017-2028

2.2 Global PEGylated Proteins Revenue Estimates and Forecasts 2017-2028

2.3 Global PEGylated Proteins Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global PEGylated Proteins Sales by Region

2.4.1 Global PEGylated Proteins Sales by Region (2017-2022)

2.4.2 Global Sales PEGylated Proteins by Region (2023-2028)

2.5 Global PEGylated Proteins Revenue by Region

2.5.1 Global PEGylated Proteins Revenue by Region (2017-2022)

2.5.2 Global PEGylated Proteins Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global PEGylated Proteins Sales by Manufacturers

3.1.1 Global Top PEGylated Proteins Manufacturers by Sales (2017-2022)

3.1.2 Global PEGylated Proteins Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of PEGylated Proteins in 2021

3.2 Global PEGylated Proteins Revenue by Manufacturers

3.2.1 Global PEGylated Proteins Revenue by Manufacturers (2017-2022)

3.2.2 Global PEGylated Proteins Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by PEGylated Proteins Revenue in 2021

3.3 Global PEGylated Proteins Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global PEGylated Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global PEGylated Proteins Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global PEGylated Proteins Sales by Type

4.1.1 Global PEGylated Proteins Historical Sales by Type (2017-2022)

4.1.2 Global PEGylated Proteins Forecasted Sales by Type (2023-2028)

4.1.3 Global PEGylated Proteins Sales Market Share by Type (2017-2028)

4.2 Global PEGylated Proteins Revenue by Type

4.2.1 Global PEGylated Proteins Historical Revenue by Type (2017-2022)

4.2.2 Global PEGylated Proteins Forecasted Revenue by Type (2023-2028)

4.2.3 Global PEGylated Proteins Revenue Market Share by Type (2017-2028)

4.3 Global PEGylated Proteins Price by Type

4.3.1 Global PEGylated Proteins Price by Type (2017-2022)

4.3.2 Global PEGylated Proteins Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global PEGylated Proteins Sales by Application

5.1.1 Global PEGylated Proteins Historical Sales by Application (2017-2022)

5.1.2 Global PEGylated Proteins Forecasted Sales by Application (2023-2028)

5.1.3 Global PEGylated Proteins Sales Market Share by Application (2017-2028)

5.2 Global PEGylated Proteins Revenue by Application

5.2.1 Global PEGylated Proteins Historical Revenue by Application (2017-2022)

5.2.2 Global PEGylated Proteins Forecasted Revenue by Application (2023-2028)

5.2.3 Global PEGylated Proteins Revenue Market Share by Application (2017-2028)

5.3 Global PEGylated Proteins Price by Application

5.3.1 Global PEGylated Proteins Price by Application (2017-2022)

5.3.2 Global PEGylated Proteins Price Forecast by Application (2023-2028)

6 North America

6.1 North America PEGylated Proteins Market Size by Type

6.1.1 North America PEGylated Proteins Sales by Type (2017-2028)

6.1.2 North America PEGylated Proteins Revenue by Type (2017-2028)

6.2 North America PEGylated Proteins Market Size by Application

6.2.1 North America PEGylated Proteins Sales by Application (2017-2028)

6.2.2 North America PEGylated Proteins Revenue by Application (2017-2028)

6.3 North America PEGylated Proteins Market Size by Country

6.3.1 North America PEGylated Proteins Sales by Country (2017-2028)

6.3.2 North America PEGylated Proteins Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe PEGylated Proteins Market Size by Type

7.1.1 Europe PEGylated Proteins Sales by Type (2017-2028)

7.1.2 Europe PEGylated Proteins Revenue by Type (2017-2028)

7.2 Europe PEGylated Proteins Market Size by Application

7.2.1 Europe PEGylated Proteins Sales by Application (2017-2028)

7.2.2 Europe PEGylated Proteins Revenue by Application (2017-2028)

7.3 Europe PEGylated Proteins Market Size by Country

7.3.1 Europe PEGylated Proteins Sales by Country (2017-2028)

7.3.2 Europe PEGylated Proteins Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific PEGylated Proteins Market Size by Type

8.1.1 Asia Pacific PEGylated Proteins Sales by Type (2017-2028)

8.1.2 Asia Pacific PEGylated Proteins Revenue by Type (2017-2028)

8.2 Asia Pacific PEGylated Proteins Market Size by Application

8.2.1 Asia Pacific PEGylated Proteins Sales by Application (2017-2028)

8.2.2 Asia Pacific PEGylated Proteins Revenue by Application (2017-2028)

8.3 Asia Pacific PEGylated Proteins Market Size by Region

8.3.1 Asia Pacific PEGylated Proteins Sales by Region (2017-2028)

8.3.2 Asia Pacific PEGylated Proteins Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America PEGylated Proteins Market Size by Type

9.1.1 Latin America PEGylated Proteins Sales by Type (2017-2028)

9.1.2 Latin America PEGylated Proteins Revenue by Type (2017-2028)

9.2 Latin America PEGylated Proteins Market Size by Application

9.2.1 Latin America PEGylated Proteins Sales by Application (2017-2028)

9.2.2 Latin America PEGylated Proteins Revenue by Application (2017-2028)

9.3 Latin America PEGylated Proteins Market Size by Country

9.3.1 Latin America PEGylated Proteins Sales by Country (2017-2028)

9.3.2 Latin America PEGylated Proteins Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa PEGylated Proteins Market Size by Type

10.1.1 Middle East and Africa PEGylated Proteins Sales by Type (2017-2028)

10.1.2 Middle East and Africa PEGylated Proteins Revenue by Type (2017-2028)

10.2 Middle East and Africa PEGylated Proteins Market Size by Application

10.2.1 Middle East and Africa PEGylated Proteins Sales by Application (2017-2028)

10.2.2 Middle East and Africa PEGylated Proteins Revenue by Application (2017-2028)

10.3 Middle East and Africa PEGylated Proteins Market Size by Country

10.3.1 Middle East and Africa PEGylated Proteins Sales by Country (2017-2028)

10.3.2 Middle East and Africa PEGylated Proteins Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 ENZON Pharmaceuticals

11.1.1 ENZON Pharmaceuticals Corporation Information

11.1.2 ENZON Pharmaceuticals Overview

11.1.3 ENZON Pharmaceuticals PEGylated Proteins Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 ENZON Pharmaceuticals PEGylated Proteins Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 ENZON Pharmaceuticals Recent Developments

11.2 Merck Sharp & Dohme

11.2.1 Merck Sharp & Dohme Corporation Information

11.2.2 Merck Sharp & Dohme Overview

11.2.3 Merck Sharp & Dohme PEGylated Proteins Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Merck Sharp & Dohme PEGylated Proteins Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Merck Sharp & Dohme Recent Developments

11.3 Roche

11.3.1 Roche Corporation Information

11.3.2 Roche Overview

11.3.3 Roche PEGylated Proteins Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Roche PEGylated Proteins Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Roche Recent Developments

11.4 Pfizer

11.4.1 Pfizer Corporation Information

11.4.2 Pfizer Overview

11.4.3 Pfizer PEGylated Proteins Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Pfizer PEGylated Proteins Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Pfizer Recent Developments

11.5 Amgen

11.5.1 Amgen Corporation Information

11.5.2 Amgen Overview

11.5.3 Amgen PEGylated Proteins Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Amgen PEGylated Proteins Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Amgen Recent Developments

11.6 UCB

11.6.1 UCB Corporation Information

11.6.2 UCB Overview

11.6.3 UCB PEGylated Proteins Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 UCB PEGylated Proteins Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 UCB Recent Developments

11.7 Crealta (Savient)

11.7.1 Crealta (Savient) Corporation Information

11.7.2 Crealta (Savient) Overview

11.7.3 Crealta (Savient) PEGylated Proteins Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Crealta (Savient) PEGylated Proteins Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Crealta (Savient) Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 PEGylated Proteins Industry Chain Analysis

12.2 PEGylated Proteins Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 PEGylated Proteins Production Mode & Process

12.4 PEGylated Proteins Sales and Marketing

12.4.1 PEGylated Proteins Sales Channels

12.4.2 PEGylated Proteins Distributors

12.5 PEGylated Proteins Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 PEGylated Proteins Industry Trends

13.2 PEGylated Proteins Market Drivers

13.3 PEGylated Proteins Market Challenges

13.4 PEGylated Proteins Market Restraints

14 Key Findings in The Global PEGylated Proteins Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample